Welcome to LookChem.com Sign In|Join Free
  • or
2-(1,1'-biphenyl-2-yloxy)ethanamine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

23314-13-8

Post Buying Request

23314-13-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

23314-13-8 Usage

Derived from

Biphenyl (aromatic hydrocarbon)

Contains

An amine group

Common uses

Synthesis of pharmaceuticals, agrochemicals, and materials

Potential applications

Therapeutic and industrial

Biological activities

Anti-inflammatory and anticancer properties

Role in organic chemistry

Building block for the preparation of other organic compounds

Check Digit Verification of cas no

The CAS Registry Mumber 23314-13-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,3,3,1 and 4 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 23314-13:
(7*2)+(6*3)+(5*3)+(4*1)+(3*4)+(2*1)+(1*3)=68
68 % 10 = 8
So 23314-13-8 is a valid CAS Registry Number.

23314-13-8Downstream Products

23314-13-8Relevant academic research and scientific papers

Discovery of a new series of 5-HT1A receptor agonists

Franchini, Silvia,Prandi, Adolfo,Sorbi, Claudia,Tait, Annalisa,Baraldi, Annamaria,Angeli, Piero,Buccioni, Michela,Cilia, Antonio,Poggesi, Elena,Fossa, Paola,Brasili, Livio

scheme or table, p. 2017 - 2020 (2010/07/07)

Starting from compounds previously identified as α1-adrenoceptor antagonists that were also found to bind to the 5-HT1A receptor, in an attempt to separate the two activities, a new series of 5-HT1A receptor agonists was identified and shown to have high potency and/or high selectivity. Of these, compound 13, which combines high selectivity (5-HT1A/α1 = 151) and good agonist potency (pD2 = 7.82; Emax = 76), was found to be the most interesting.

Substituted alpha-aminosulphonyl-acetohydroxamic acids as therapeutic agents

-

, (2008/06/13)

Compounds of formula (I): where the substituents are as defined herein, and salts thereof, are matrix metalloprotease inhibitors.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 23314-13-8